Pacira BioSciences' Tax Provisions fell 11.24% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 43.07%. This contributed to the annual value of $36.5 million for FY2024, which is 84.61% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Tax Provisions is $4.1 million, which was up 40.14% from $2.9 million recorded in Q2 2025.
Pacira BioSciences' Tax Provisions' 5-year high stood at $17.7 million during Q2 2024, with a 5-year trough of -$8.0 million in Q4 2022.
Moreover, its 3-year median value for Tax Provisions was $4.7 million (2024), whereas its average is $6.1 million.
Its Tax Provisions has fluctuated over the past 5 years, first skyrocketed by 15,735.71% in 2021, then slumped by 1,588.84% in 2023.
Over the past 5 years, Pacira BioSciences' Tax Provisions (Quarterly) stood at -$1.1 million in 2021, then plummeted by 645.88% to -$8.0 million in 2022, then spiked by 211.10% to $8.8 million in 2023, then climbed by 7.18% to $9.5 million in 2024, then decreased by 11.24% to $4.1 million in 2025.
Its last three reported values are $4.1 million in Q3 2025, $2.9 million for Q2 2025, and $3.9 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value